Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD

K-Number: K182138 · 2018-09-05

ApplicantEleckta Limited
Decision Date2018-09-05
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is a medical device manufactured by Eleckta Limited. It received FDA 510(k) clearance on 2018-09-05 under approval number K182138. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD?

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is a medical device that received FDA 510(k) clearance on 2018-09-05. It is manufactured by Eleckta Limited. The 510(k) number is K182138.

When was Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD approved by the FDA?

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD received FDA 510(k) clearance on 2018-09-05, under approval number K182138.

What company makes Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD?

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is manufactured by Eleckta Limited.

What is the FDA product code for Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD?

The FDA product code for Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is IYE.

Related Clinical Trials

NCT07614997 Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck NOT_YET_RECRUITING NCT05003843 BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis ACTIVE_NOT_RECRUITING NCT07499128 Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event ENROLLING_BY_INVITATION NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT05701917 DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis RECRUITING NCT03736226 A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China ACTIVE_NOT_RECRUITING

Related PubMed Literature

PMID: 41790854 A Substance Use Disorder Virtual Treatment and Research Platform: A Proof of Concept. IEEE pulse (2025) PMID: 41483832 Emerging nanodelivery systems for cuproptosis induction: design strategies and multidimensional regulatory mechanisms. International journal of pharmaceutics (2026) PMID: 41271017 Lymphedema Imaging and AI: A Review of Diagnostic Modalities, Biomarkers, and Clinical Integration. Biomedical journal (2025) PMID: 41251011 Effectivity of the Dehydrated Human Amnion/Chorion Membrane Allograft for Diabetic Foot Ulcers in Japan: A Case Series. International wound journal (2025)

Related Devices (Code: IYE)

K162476Varian High Energy Linear AcceleratorVarian Medical Systems, Inc. K161400ImagingRing SystemMedphoton GmbH K162468ClearCheckRadformation K162355Raycast MammoRx Carbon Fibre Breast BoardOrfit Industries NV K162577Dosimetry Check Version 5 Release 1Math Resolutions, LLC K162265CushionCast Moldable CushionsIzi Medical Products, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑